A system that required physicians, rather than support staff, to approve low-utility imaging exams was able to cut their incidence by more than half, according to a study from Massachusetts General Hospital reported Sunday at the 2009 RSNA meeting.
A system that required physicians, rather than support staff, to approve low-utility imaging exams was able to cut their incidence by more than half, according to a study from Massachusetts General Hospital reported Sunday at the 2009 RSNA meeting.
Low-utility exams fell from 5.43% of those approved to 1.92% in before- and after-system changes monitored over sequential nine-month periods at MGH, said the principal researcher, Dr. Vartan Vartanians.
The utility ranking system used at MGH mirrors the American College of Radiology's Appropriateness Criteria. Imaging studies entered through an e-ordering system are ranked on a color-coded, 1 to 9 scale based on how likely they are to yield information that would shed light on the clinical question posed by the requesting physician. High-utility exams are coded green and get a 6 to 9 ranking. Low-utility exams are coded red and get a 1 to 3 ranking.
The researchers ran a nine-month control period beginning in April of 2006, collecting data from 42,000 exams. They then implemented a system prohibiting support staff from ordering the low-utility exams and repeated their survey over a nine-month period beginning in April 2007, collecting data on approximately 76,000 exams. Low-utility exams could still be ordered by physicians.
Among their findings:
Vartanians was asked whether there were complaints from clinicians about the new system. He acknowledged that there most likely were, but said the percentage was probably small. In addition, the new system came with offsetting advantages including less paperwork and fewer phone calls for approval.
"I think we made their lives easier," he said.
Can MRI-Based AI Bolster Biopsy Decision-Making in PI-RADS 3 Cases?
December 9th 2024In patients with PI-RADS 3 lesion assessments, the combination of AI and prostate-specific antigen density (PSAD) level achieved a 78 percent sensitivity and 93 percent negative predictive value for clinically significant prostate cancer (csPCa), according to research presented at the Radiological Society of North American (RSNA) conference.
The Reading Room: Artificial Intelligence: What RSNA 2020 Offered, and What 2021 Could Bring
December 5th 2020Nina Kottler, M.D., chief medical officer of AI at Radiology Partners, discusses, during RSNA 2020, what new developments the annual meeting provided about these technologies, sessions to access, and what to expect in the coming year.
RSNA 2020: Addressing Healthcare Disparities and Access to Care
December 4th 2020Rich Heller, M.D., with Radiology Partners, and Lucy Spalluto, M.D., with Vanderbilt University School of Medicine, discuss the highlights of their RSNA 2020 session on health disparities, focusing on the underlying factors and challenges radiologists face to providing greater access to care.
New Interventional Radiology Research Shows Merits of Genicular Artery Embolization for Knee OA
December 3rd 2024In a cohort of over 160 patients with knee osteoarthritis (OA), including grade 4 in nearly half of the cases, genicular artery embolization led to an 87 percent improvement in the quality of life index, according to research presented at the recent RSNA conference.
Siemens Healthineers Debuts New Photon-Counting CT Systems at RSNA
December 2nd 2024Debuting at the Radiological Society of North American (RSNA) conference, the new photon-counting computed tomography (PPCT) scanners Naeotom Alpha.Pro and Naeotom Alpha.Prime reportedly combine rapid scan times with high-resolution precision.